Concepedia

Publication | Closed Access

Ibrexafungerp: An orally active β-1,3-glucan synthesis inhibitor

DOI

48

Citations

12

References

2020

Year

James M. Apgar, Robert R. Wilkening, Dann L. Parker, Dongfang Meng, Kenneth J. Wildonger, Donald M. Sperbeck, Mark L. Greenlee, James M. Balkovec, Amy Flattery, George K. Abruzzo,
Bioorganic & Medicinal Chemistry Letters

References

YearCitations

Page 1